GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech

Post date: 2018-01-16 04:20:55
Views: 261
 Leaning on its in-house life sciences expertise GV has backed another biotech startup in the UK, co-leading a £20 million ($27.1M) Series A in Oxford University spinout Vaccitech, which is developing a universal flu vaccine. Read More
Please click Here to read the full story.
 
Other Top and Latest Questions:
Top Chef: Chef's Test
Dog personality changes on prednisone
Looking for biology/naturalist educational tour kind of experiences.
custom keyboard/app/toggle that would help organize my pics?
Abstaining from alcohol makes my mornings worse?
How did you navigate a serious threat to your long-term relationship?
How can I change the username link color?
The Regime: Midnight Feast
Shogun: Ladies of the Willow World Show Only
3 Body Problem: Judgment Day Books Included